Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFondazione del Piemonte per l'Oncologia

About this trial

This study evaluates whether a 7-day ketogenic dietary regimen before 2-\[18F\]FDG PET/CT can improve the diagnostic accuracy of imaging in adults with suspected or histologically confirmed lepidic-predominant lung adenocarcinoma (LPA). LPA frequently shows low glucose metabolism and may yield false-negative FDG PET/CT results. Approximately 30 participants will undergo a tailored ketogenic diet for 7 days before PET/CT. Imaging results will be compared with histopathology and additionally assessed against literature-reported diagnostic performance and a matched retrospective institutional cohort.

Eligibility criteria

Qualifiers

Written informed consent.

Age 18 years or older.

CT evidence of a lung nodule suspicious for LPA or lung biopsy positive for LPA.

Target nodule diameter at least 10 mm.

Disqualifiers

Not suitable for prolonged imaging procedures.

Renal failure.

Type 1 diabetes mellitus.

Pancreatitis.

Trial design

Treatments tested in this trial

  • Ketogenic diet
  • 2-[18F]FDG PET/CT

Treatment groups

30 Participants
are divided into 1 treatment group